Cipla Limited (CIPLA) — Announcement

· NSE Neutral
📢 Key Event
Crisil assigns Crisil ESG 69 and Crisil Core ESG 66 ratings to Cipla
💡 Investor Takeaway
The ESG ratings reflect Cipla's sustainability performance and may influence investor perception of its long-term risk profile.

Cipla announced that Crisil ESG Ratings assigned it a Crisil ESG 69 and Crisil Core ESG 66 rating, received on 11 July 2026, as part of its compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30. The filing confirms the ESG rating details and the date of receipt, highlighting the company's focus on sustainability disclosures.

📄 View Original Announcement (PDF)

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,15,682.55 Cr P/E: 25.4 ROE: 14.6% ROCE: 19.4%

View full CIPLA stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CIPLA — Free

Free account · 2 AI queries/day